🟢 Ardelyx is trading 11.73% up today in pre-market — no clear catalyst identified

Ardelyx is trading 11.73% up in pre-market at $4.00 after rising from the September 11 close of $3.58, with no clear catalyst identified.

• No company-specific announcement, filing, FDA decision, reimbursement development, or analyst action dated September 14, 2026 was identified.
• The September 10 Cantor conference discussed growth, payer pressure, and 2027 profitability but did not explicitly connect those comments to this move.
• Broader markets are weaker, with no confirmed macro explanation apparent.